Literature DB >> 1078934

Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration.

H D Wilson, K C Haltalin.   

Abstract

Sixty-two children with Haemophilus meningitis were treated with ampicillin sodium, 200 mg/kg/day for ten days. Thirty-one received the drug intravenously (IV) for ten days; the other 31 patients received ampicillin IV for five days (except for one test dose given intramuscularly [IM] on day 2) followed by IM administration of ampicillin the last five days. Ampicillin concentrations in cerebrospinal fluid (SCF) were higher one hour after IV administration, but at two and four hours, concentrations were greater after IM doses. Responses to therapy and rates of complications were similar in the two groups. Fourteen patients had positive CSF cultures on day 2. Ten of these were isolated only on Levinthal medium and would have been overlooked with routine culture methods. All organisms were ampicillin-susceptible and all CSF cultures were negative by 48 hours. More patients with delayed sterilization had neurologic sequelae (78%) than patients with prompt CSF sterilization (13%). The schedule of five days of IV treatment followed by five days of IM therapy was pharmacologically and clinically as effective as ten days of IV therapy and has practical advantages.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078934     DOI: 10.1001/archpedi.1975.02120390042009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  12 in total

1.  Penetration of cefamandole into spinal fluid.

Authors:  E A Steinberg; G D Overturf; L J Baraff; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

Review 2.  Bacterial meningitis. Some aspects of diagnosis and treatment.

Authors:  G Hambleton; P A Davies
Journal:  Arch Dis Child       Date:  1975-09       Impact factor: 3.791

3.  Efficacy of gatifloxacin in experimental Escherichia coli meningitis.

Authors:  I Lutsar; I R Friedland; H S Jafri; L Wubbel; W Ng; F Ghaffar; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

4.  Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.

Authors:  M Del Rio; G H McCracken; J D Nelson; D Chrane; S Shelton
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

5.  Bacterial meningitis: which regimen?

Authors:  G D Overturf; P F Wehrle
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546

6.  Once-daily gentamicin therapy for experimental Escherichia coli meningitis.

Authors:  A Ahmed; M M París; M Trujillo; S M Hickey; L Wubbel; S L Shelton; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

7.  Ampicillin dosage in bacterial meningitis with special reference to Haemophilus influenzae.

Authors:  G R Greene; G D Overturf; P F Wehrle
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.

Authors:  M de los A del Rio; D F Chrane; S Shelton; G H McCracken; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

10.  Comparative trial of carbenicillin and ampicillin therapy for purulent meningitis.

Authors:  G D Overturf; E A Steinberg; A E Underman; J Wilkins; J M Leedom; A W Mathies; P F Wehrle
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.